Blend Labs, Inc.
NYSE:BLNDSoftware - Application
-$0.03 today
- Market cap
- $216.33M
- Beta
- 1.09
- P/E (TTM)
- -71.2
- EPS (TTM)
- -$0.02
Volume 0.72M
Average 3.92M
BLND Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
Blend Labs, Inc.NYSE: BLND
Cash & Equivalents · Q1 FY2026 · quarter ended Mar 2026
Cash & equivalents falls 30.0% from a year ago
Cash & equivalents stood at $39.37M at the end of Q1 FY2026, down 30.0% from a year earlier and down 9.7% from the prior quarter. Over 3 fiscal years it compounded at -29.5% a year.
Context
- Cash & equivalents amounted to 24.4% of total assets at the end of Q1 FY2026, down 5.5 pp from a year earlier.
- Cash & equivalents increased in 2 of the last 3 fiscal years.
What to watch
Whether cash & equivalents keeps falling in the next quarterly balance sheet after a -30.0% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2025
- 43.58M USD
- Year-over-year change
- +3.2%
- 4-year CAGR
- -32.8%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 43.58M | +3.2% |
| FY2024 | 2024-12-31 | 42.24M | +36.4% |
| FY2023 | 2023-12-31 | 30.96M | -75.1% |
| FY2022 | 2022-12-31 | 124.2M | -41.7% |
| FY2021 | 2021-12-31 | 213.08M | — |
Cash & Equivalents vs competitors
How BLND compares with its peers on the latest reported figures
- BLND's Mar 2026 cash & equivalents of $39.37M is the 8th highest of the 10 companies compared; the peer median is $63.87M.
- Its year-over-year change of -30.0% is the 7th highest of 10, against a peer median of -12.9%.
- Cash & equivalents amounts to 24.4% of total assets for BLND, versus a peer median of 24.9%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
LAESSEALSQ Corp | Dec 2025 | $417.66M | +393.5% | +368.7% | 82.8% |
| Mar 2026 | $164.6M | -44.6% | +118.8% | 34.3% | |
| Mar 2026 | $139.87M | -51.2% | -4.9% | 37.3% | |
| Mar 2026 | $88.27M | -12.9% | -4.1% | 7.4% | |
| Mar 2026 | $63.87M | +10.2% | +44.9% | 8.9% | |
| Mar 2026 | $63.4M | -31.0% | -30.1% | 24.9% | |
| Mar 2026 | $43.45M | +25.6% | +11.0% | 38.6% | |
| Mar 2026 | $39.37M | -30.0% | -29.5% | 24.4% | |
| Mar 2026 | $37.96M | -5.3% | -20.5% | 4.5% | |
| Mar 2026 | $16.79M | -20.4% | -13.6% | 4.9% | |
| Peer median (excluding BLND) | $63.87M | -12.9% | -4.1% | 24.9% | |
Competitors are the stored peer set for BLND. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 213.08M | 124.2M | 30.96M | 42.24M | 43.58M |
| Short-term Investments | 334.15M | 229.95M | 105.96M | 56.23M | 24.74M |
| Net Receivables | 39.44M | 23.97M | 19.94M | 19.9M | 14.05M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 7.85M | 5.82M | 2.89M | 7.9M | 8.65M |
| Total Current Assets | 613.02M | 396.1M | 169.84M | 135.17M | 97.86M |
| Property, Plant & Equipment (Net) | 20.87M | 17.41M | 12.51M | 13.79M | 24.39M |
| Goodwill | 287.23M | 0 | 0 | 0 | 0 |
| Intangible Assets | 173.01M | 2.13M | 2.11M | 2.08M | 0 |
| Long-term Investments | 0 | 0 | 5.38M | 9.8M | 40.07M |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 18.36M | 17.13M | 16.23M | 17.17M | 7.72M |
| Total Non-current Assets | 499.47M | 36.67M | 36.23M | 42.84M | 72.18M |
| Total Assets | 1.11B | 432.76M | 206.07M | 178.01M | 170.05M |
| Account Payables | 6.16M | 1.26M | 2.17M | 2.42M | 1.83M |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 8.07M | 8.7M | 8.98M | 19.24M | 19.46M |
| Other Current Liabilities | 18.14M | 10.06M | 5.56M | 4.05M | 17.99M |
| Total Current Liabilities | 60.03M | 35.47M | 31.57M | 38.95M | 39.53M |
| Long-term Debt | 213.84M | 216.8M | 138.33M | 0 | 159.5M |
| Deferred Tax Liabilities | 2.86M | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 10.55M | 5.48M | 2.23M | 142.24M | 346K |
| Total Non-current Liabilities | 241.87M | 233.37M | 147.54M | 143.04M | 161.06M |
| Total Liabilities | 301.9M | 268.84M | 179.12M | 181.99M | 200.6M |
| Common Stock | 2K | 2K | 2K | 2K | 2K |
| Retained Earnings | (442.77M) | (1.16B) | (1.34B) | (1.38B) | (1.39B) |
| Accumulated OCI | (808K) | (708K) | 441K | 602K | 597K |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 35.95M | 40.75M | 46.19M | 52.38M | 0 |
| Total Equity | 810.59M | 163.92M | 26.95M | (3.98M) | (30.55M) |
| Total Debt | 232.31M | 231.98M | 149.7M | 3.83M | 160.97M |
| Net Debt | 19.22M | 107.78M | 118.73M | (38.41M) | 117.39M |
Blend Labs, Inc.
NYSE:BLND
Intrinsic Alpha fair value
Locked
Current Price
$0.92
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.